IL313097A - Methods of treating cns disorders - Google Patents

Methods of treating cns disorders

Info

Publication number
IL313097A
IL313097A IL313097A IL31309724A IL313097A IL 313097 A IL313097 A IL 313097A IL 313097 A IL313097 A IL 313097A IL 31309724 A IL31309724 A IL 31309724A IL 313097 A IL313097 A IL 313097A
Authority
IL
Israel
Prior art keywords
methods
nervous system
central nervous
system disorders
treating central
Prior art date
Application number
IL313097A
Other languages
English (en)
Hebrew (he)
Inventor
Congxin Liang
Wei Tang
Original Assignee
Hangzhou Highlightll Pharmaceutical Co Ltd
Congxin Liang
Wei Tang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hangzhou Highlightll Pharmaceutical Co Ltd, Congxin Liang, Wei Tang filed Critical Hangzhou Highlightll Pharmaceutical Co Ltd
Publication of IL313097A publication Critical patent/IL313097A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL313097A 2021-09-13 2022-08-22 Methods of treating cns disorders IL313097A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202111069990 2021-09-13
PCT/CN2022/113807 WO2023035913A1 (en) 2021-09-13 2022-08-22 Methods of treating cns disorders

Publications (1)

Publication Number Publication Date
IL313097A true IL313097A (en) 2024-07-01

Family

ID=85506085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313097A IL313097A (en) 2021-09-13 2022-08-22 Methods of treating cns disorders

Country Status (8)

Country Link
US (1) US20250032465A1 (https=)
EP (1) EP4419101A4 (https=)
JP (1) JP2024543198A (https=)
CN (2) CN116490180B (https=)
AU (1) AU2022342095A1 (https=)
CA (1) CA3239065A1 (https=)
IL (1) IL313097A (https=)
WO (1) WO2023035913A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023244611A1 (en) * 2022-06-13 2023-12-21 Emory University Uses of jak inhibitors in the management of inflammation-associated depression and central nervous system (cns) pathologies
CN120152713A (zh) * 2022-07-29 2025-06-13 昂胜医疗科技公司 三环芳基衍生物及其组合物和方法
WO2025224600A1 (en) 2024-04-21 2025-10-30 Biohaven Therapeutics Ltd. Treatment of alpha-synucleinopathies and neuroprotection
WO2025248468A1 (en) * 2024-05-28 2025-12-04 Biohaven Therapeutics Ltd. Use of tyk2/jak1 inhibitors to treat amyloid-related imaging abnormalities (aria)
WO2026032213A1 (zh) * 2024-08-08 2026-02-12 普罗思特(南京)生物科技有限公司 取代的三环衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2473579B (en) * 2008-06-30 2013-01-30 Biotechnology Res Corp Ltd Stat3 and TYK2 as drug targets for neurodegenerative diseases
CN105636962B (zh) * 2013-10-15 2017-10-13 靳博涵 新型化合物、用途及其制备方法
MX390005B (es) * 2016-10-03 2025-03-20 Hangzhou Highlightll Pharmaceutical Co Ltd Inhibidores selectivos de jak1 novedosos y usos de los mismos.
BR112021024533A2 (pt) 2019-06-06 2022-01-18 Highlightll Pharmaceutical Hainan Co Ltd Método de síntese de composto de furoimidazopiridina, forma cristalina de composto de furoimidazopiridina, e forma cristalina de sal do mesmo
WO2020244349A1 (zh) * 2019-06-06 2020-12-10 广州高瓴制药有限公司 呋喃并咪唑并吡啶类化合物的合成方法、多晶型物、及盐的多晶型物

Also Published As

Publication number Publication date
JP2024543198A (ja) 2024-11-19
AU2022342095A1 (en) 2024-06-27
US20250032465A1 (en) 2025-01-30
CN116490180B (zh) 2024-03-22
CN118059096A (zh) 2024-05-24
EP4419101A1 (en) 2024-08-28
CA3239065A1 (en) 2023-03-16
EP4419101A4 (en) 2025-09-03
WO2023035913A1 (en) 2023-03-16
CN116490180A (zh) 2023-07-25

Similar Documents

Publication Publication Date Title
IL290455A (en) Methods of treating psychological and brain disorders
IL313097A (en) Methods of treating cns disorders
IL280919A (en) Methods of treating aging-related disorders
LT4084791T (lt) Specifiniai triptaminai, skirti nuotaikos sutrikimams gydyti
EP4010072A4 (en) TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES
MX2021010193A (es) Azepino-indoles y otros heterociclos para el tratamiento de trastornos cerebrales.
IL269174A (en) Methods for treating complement-mediated diseases and disorders
PL3865102T3 (pl) Urządzenie i sposób leczenia zaburzeń neurologicznych układu słuchowego
HUE054092T2 (hu) Központi idegrendszeri zavarok kezelésére szolgáló kompozíciók és eljárások
IL294594A (en) Methods of treating pemphigus
EA201992474A3 (ru) Агонисты 5ht для лечения нарушений
EP3349760A4 (en) COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDER
MX2018000778A (es) Metodos para tratar trastornos mediados por hepcidinas.
HUE051488T2 (hu) Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
IL262803B (en) Methods of treating circadian rhythm sleep disorders
MA47212A (fr) Méthodes de traitement de troubles neurologiques
DK3433266T3 (da) Fremgangsmåder til behandling af mitokondrieforstyrrelser
MX385914B (es) Método para tratar un tumor cerebral
ES3064798T3 (en) Phototherapy system for treating nasal disorders
EP3471746A4 (en) METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS
EP3826650A4 (en) METHODS OF TREATMENT OF NEUROLOGICAL DISEASES
IL288655A (en) Preparations and methods for the treatment of central nervous system disorders
EP3621434A4 (en) METHOD OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
HUE055840T2 (hu) Készülék és eljárás a hallórendszer neurológiai rendellenességeinek kezelésére
IL283503A (en) Combined treatment of primary central nervous system lymphoma